Physician profile
Richard A Benavides
NPI 1497893754
$310.83
in general payments reported to CMS, 2019-2025
12 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.63 · 2024: $52.66 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $51.27 | 2025 | Nuzyra |
| Mimedx Group, INC. | $47.82 | 2025 | |
| Tactile Systems Technology INC | $31.27 | 2025 | Flexitouch Plus, Nimbl |
| Polynovo North America LLC | $30.02 | 2024 | Novosorb Btm |
| Cashflow Solutions, LLC | $22.77 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Boston Scientific Corporation | $22.64 | 2024 | |
| Smith+Nephew, INC. | $20.85 | 2025 | Grafix |
| Hartmann USA, INC. | $19.11 | 2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $17.20 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Apollo Endosurgery US INC | $16.60 | 2023 | Overstitch Endoscopic Suturing System |
| Solventum Corporation | $16.25 | 2025 | Activ.A.C. |
| Cumberland Pharmaceuticals, INC. | $15.03 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Benavides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.